In contrast, in sites where SCLC transformation did not occur (possibly also prevented by the concomitant chemotherapy) the appearance of clones with T790M mutation could have ensured further progression together with the parallel constitutive FGFR3-signaling. The gene discussed is FGFR3; the disease is small cell lung carcinoma.